a Chinese big pharma bought Sirtex, the ASX-listed liver spheres cancer treatment company.
I believe the same company just “partnered” with Telix, another ASX-listed cancer treatment company.
the Chinese government has cornered the market in rare earth metal production and is now threatening to restrict which countries get to buy the products. At the moment they are thinking of restricting the US and Japan...
I am quite spooked by this...what if a Chinese big pharma offers RAC shareholders a mouth-watering deal? How many share holders would say no on principle?
FTO and link to AML and breast cancer treatment, page-11
-
- There are more pages in this discussion • 29 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.61 |
Change
-0.055(3.31%) |
Mkt cap ! $273.4M | |||
| Open | High | Low | Value | Volume |
| $1.66 | $1.68 | $1.61 | $271.5K | 166.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1996 | $1.61 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.68 | 1305 | 2 |
View Market Depth
| Last trade - 16.10pm 26/07/2024 (20 minute delay) ? |
| RAC (ASX) Chart |